Avid Bioservices Inc (CDMO)

[Thurly]

I'd rewrite your sentence as follows:
The complaint says ABV was willing to look at the data, but when the dose mixup was discovered, they backed out because what the company had been presenting was false and misleading.

To be clear, it doesn't say that additional problems with the data were discovered.

I take the document as being investor neutral. It accords with what is already known about the facts and Peregrine's potential liability.

IMO